THE ROLE OF RECORD LINKAGE IN POSTMARKETING DRUG SURVEILLANCE

[11] REPLACEMENT ESTROGENS AND ENDOMETRIAL CANCER [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1979, 300 (05) : 218 - 222

[12] VAGINAL SPERMICIDES AND CONGENITAL DISORDERS [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1981, 245 (13): : 1329 - 1332

[13] JONES JK, 1984, ACTA MED SCAND, V683, P127

[14] POST-MARKETING SURVEILLANCE - HOW MANY PATIENTS [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1981, 2 (04) : 93 - 94

[15] POSTMARKETING SURVEILLANCE OF ADVERSE REACTIONS TO DRUGS [J]. BRITISH MEDICAL JOURNAL, 1984, 288 (6421) : 879 - 880

[16] SAMPLE SIZE REQUIREMENTS IN COHORT AND CASE-CONTROL STUDIES OF DISEASE [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1974, 99 (06) : 381 - 384

[17] RECORD LINKAGE FOR DRUG-MONITORING [J]. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 1981, 35 (01) : 25 - 31

[18] SKEGG DCG, 1980, MONITORING DRUG SAFE, P337

[19] POST-MARKETING SURVEILLANCE OF NEW DRUGS .1. REVIEW OF OBJECTIVES AND METHODOLOGY [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 19 (2-3) : 85 - 94

[20] 1977, INT CLASSIFICATION D, V2

[11] REPLACEMENT ESTROGENS AND ENDOMETRIAL CANCER [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1979, 300 (05) : 218 - 222

[12] VAGINAL SPERMICIDES AND CONGENITAL DISORDERS [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1981, 245 (13): : 1329 - 1332

[13] JONES JK, 1984, ACTA MED SCAND, V683, P127

[14] POST-MARKETING SURVEILLANCE - HOW MANY PATIENTS [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1981, 2 (04) : 93 - 94

[15] POSTMARKETING SURVEILLANCE OF ADVERSE REACTIONS TO DRUGS [J]. BRITISH MEDICAL JOURNAL, 1984, 288 (6421) : 879 - 880

[16] SAMPLE SIZE REQUIREMENTS IN COHORT AND CASE-CONTROL STUDIES OF DISEASE [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1974, 99 (06) : 381 - 384

[17] RECORD LINKAGE FOR DRUG-MONITORING [J]. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 1981, 35 (01) : 25 - 31

[18] SKEGG DCG, 1980, MONITORING DRUG SAFE, P337

[19] POST-MARKETING SURVEILLANCE OF NEW DRUGS .1. REVIEW OF OBJECTIVES AND METHODOLOGY [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 19 (2-3) : 85 - 94

[20] 1977, INT CLASSIFICATION D, V2